A repurposed Type 2 diabetes drug helped teens with obesity lose a significant amount of body weight, lowered their risk factors for cardiovascular disease, and improved their weight-related quality of life over a 68-week clinical trial, researchers reported this week in the New England Journal of Medicine.
[
add
]
[
|
|
...
]